Copyright
©The Author(s) 2021.
World J Clin Cases. Mar 26, 2021; 9(9): 2110-2122
Published online Mar 26, 2021. doi: 10.12998/wjcc.v9.i9.2110
Published online Mar 26, 2021. doi: 10.12998/wjcc.v9.i9.2110
Table 3 Development of transdermal patch[14]
Classification | Characteristic |
First-generation transdermal patch | The drug should have suitable properties (highly potency, low molecular weight and lipophilic) to solve the problem of low oral bioavailability, to reduce the frequency of drug administration or to achieve stable drug administration |
Second-generation transdermal patch | This generation of patch can promote and improve the percutaneous absorption of small molecule drugs by means of a chemical penetration enhancer, ion introduction or ultrasound |
Third-generation transdermal patch | These patches help to promote percutaneous absorption of macromolecules, including therapeutic proteins and vaccines |
- Citation: Ma K, Jiang W, Wang YX, Wang L, Lv Y, Liu JF, Liu RG, Liu H, Xiao LZ, Du DP, Lu LJ, Yang XQ, Xia LJ, Huang D, Fu ZJ, Peng BG, Liu YQ. Expert consensus of the Chinese Association for the Study of Pain on pain treatment with the transdermal patch. World J Clin Cases 2021; 9(9): 2110-2122
- URL: https://www.wjgnet.com/2307-8960/full/v9/i9/2110.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i9.2110